UP!
 "All Around You"
|
|
|
Type
|
Public |
|---|---|
| Traded as | NASDAQ: QRVO S&P 500 Component |
| Industry | Wireless handsets, base station, broadband communications, military, foundry |
| Founded | 2015 |
| Headquarters | Greensboro, North Carolina (with other campus in Hillsboro, Oregon) |
| Products | GaAs, GaN, SAW filters, and BAW foundry services and components |
|
Number of employees
|
8000 |
| Subsidiaries | TriQuint Semiconductor RF Micro Devices |
| Website | qorvo.com |
Qorvo is an American semiconductor company that designs, manufactures, and supplies radio-frequency systems and solutions for applications that drive wireless and broadband communications, as well as foundry services. The company, which trades on NASDAQ, was created by the merger of TriQuint Semiconductor and RF Micro Devices, which was announced in 2014 and completed on January 1, 2015. The headquarters for the company originally were in both Hillsboro, Oregon (home of TriQuint), and Greensboro, North Carolina (home of RFMD), but in mid-2016 the company began referring to its North Carolina site as its exclusive headquarters.
Qorvo was created on January 1, 2015, with the merger of TriQuint Semiconductor and RF Micro Devices (RFMD). In June 2015, the new company became a component of the S&P 500, replacing tobacco company Lorillard. At the time of joining the S&P 500, Qorvo was valued at $12 billion. The company employs more than 8,000 people. As of mid-2016, the Oregon plant alone was employing almost 1,000 people.
Pronounced "kor-vo", the name is intended to reflect the "core technologies and innovations" the companies plan to enable following their combination. The name's first syllable is meant to evoke "chorus" – people (TriQuint and RFMD) working in unison, as well as "core" technology. The second syllable, "vo", is meant to indicate voyage or travel through air or space.
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q2 2023 | 2022-11-01 | Future report Set alerts | |
| Q1 2023 | 2022-08-03 | 2.25 | 2.25 |
| Q4 2022 | 2022-05-04 | 3.12 | 3.12 |
| Q3 2022 | 2022-02-02 | 2.98 | 2.98 |
| Q2 2022 | 2021-11-03 | 3.42 | 3.42 |
| Q1 2022 | 2021-08-04 | 2.83 | 2.83 |
| Q4 2021 | 2021-05-05 | 2.74 | 2.74 |
| Q3 2021 | 2021-02-03 | 3.08 | 3.08 |
| Q2 2021 | 2020-11-04 | 2.43 | 2.43 |
| Q1 2021 | 2020-07-29 | 1.50 | 1.50 |
| 2016-07-06 | Reiterated Rating | Drexel Hamilton | Buy | |
| 2016-07-06 | Reiterated Rating | KeyCorp | Hold | |
| 2016-07-01 | Downgrade | Mizuho | Buy to Neutral | $55.00 |
| 2016-06-27 | Initiated Coverage | Morgan Stanley | Equal to Equal Weight | $56.00 |
| 2016-06-15 | Reiterated Rating | Brean Capital | Buy | |
| 2016-06-09 | Upgrade | Citigroup Inc. | Sell to Neutral | $40.00 to $57.00 |
| 2016-05-24 | Initiated Coverage | Credit Agricole | Underperform | |
| 2016-05-24 | Initiated Coverage | Credit Agricole SA | Underperform | |
| 2016-05-22 | Reiterated Rating | Brean Capital | Buy | $62.00 |
| 2016-05-05 | Upgrade | BMO Capital Markets | Outperform | $57.00 to $50.00 |
| 2016-05-05 | Reiterated Rating | Goldman Sachs | Hold | $48.00 |
| 2016-05-05 | Boost Price Target | MKM Partners | Buy | $63.00 to $64.00 |
| 2016-05-05 | Boost Price Target | Craig Hallum | Buy | $56.00 to $58.00 |
| 2016-05-05 | Boost Price Target | Brean Capital | Buy | $55.00 to $62.00 |
| 2016-05-05 | Boost Price Target | Needham & Company LLC | Buy | $50.00 to $53.00 |
| 2016-05-05 | Boost Price Target | Cowen and Company | Outperform | $50.00 to $55.00 |
| 2016-05-05 | Reiterated Rating | Goldman Sachs Group Inc. | Hold | $48.00 |
| 2016-05-04 | Reiterated Rating | Oppenheimer | Hold | |
| 2016-05-04 | Reiterated Rating | Oppenheimer Holdings Inc. | Hold | |
| 2016-05-02 | Lower Price Target | Goldman Sachs | Neutral | $47.00 to $44.00 |
| 2016-04-27 | Reiterated Rating | Needham & Company LLC | Buy | |
| 2016-04-19 | Downgrade | Raymond James | Strong-Buy to Outperform | |
| 2016-04-19 | Downgrade | Raymond James Financial Inc. | Strong-Buy to Outperform | |
| 2016-04-18 | Initiated Coverage | Cowen and Company | Market Perform | $50.00 |
| 2016-04-12 | Boost Price Target | Mizuho | Buy | $50.00 to $55.00 |
| 2016-04-11 | Reiterated Rating | MKM Partners | Buy | $65.00 to $63.00 |
| 2016-04-04 | Reiterated Rating | Stephens | Buy | |
| 2016-03-28 | Reiterated Rating | Barclays | Hold | $46.00 to $50.00 |
| 2016-03-28 | Reiterated Rating | Barclays PLC | Hold | $46.00 to $50.00 |
| 2016-03-21 | Reiterated Rating | Bank of America | Buy | $56.00 |
| 2016-03-21 | Reiterated Rating | Bank of America Corp. | Buy | $56.00 |
| 2016-02-24 | Reiterated Rating | Oppenheimer | Market Perform | |
| 2016-02-23 | Reiterated Rating | Needham & Company LLC | Buy | $54.00 |
| 2016-02-11 | Reiterated Rating | Needham & Company LLC | Buy | $55.00 to $54.00 |
| 2016-02-08 | Reiterated Rating | Oppenheimer | Market Perform | |
| 2016-02-06 | Reiterated Rating | BMO Capital Markets | Buy | |
| 2016-02-05 | Lower Price Target | DA Davidson | Buy | $65.00 |
| 2016-02-05 | Lower Price Target | Canaccord Genuity | Buy | $62.00 to $55.00 |
| 2016-02-05 | Lower Price Target | BMO Capital Markets | Outperform | $55.00 to $50.00 |
| 2016-02-05 | Downgrade | Citigroup Inc. | Neutral to Sell | |
| 2016-02-03 | Downgrade | Goldman Sachs | Buy to Neutral | $42.00 |
| 2016-01-27 | Lower Price Target | Citigroup Inc. | $50.00 to $42.00 | |
| 2016-01-24 | Reiterated Rating | DA Davidson | Buy | |
| 2016-01-20 | Reiterated Rating | Brean Capital | Buy | $55.00 |
| 2016-01-15 | Reiterated Rating | Chardan Capital | Buy | |
| 2016-01-09 | Reiterated Rating | Northland Securities | Buy | |
| 2016-01-09 | Reiterated Rating | Stephens | Buy | |
| 2016-01-09 | Reiterated Rating | Drexel Hamilton | Buy | |
| 2016-01-08 | Lower Price Target | Northland Securities | Outperform | $75.00 to $55.00 |
| 2016-01-08 | Lower Price Target | DA Davidson | Buy | $80.00 to $75.00 |
| 2016-01-08 | Lower Price Target | Craig Hallum | Buy | $80.00 to $60.00 |
| 2016-01-08 | Lower Price Target | Canaccord Genuity | Buy | $77.00 to $62.00 |
| 2016-01-08 | Lower Price Target | Needham & Company LLC | Buy | $64.00 to $55.00 |
| 2016-01-08 | Lower Price Target | Mizuho | Buy | $65.00 to $50.00 |
| 2016-01-08 | Reiterated Rating | Pacific Crest | Hold | |
| 2016-01-07 | Lower Price Target | Citigroup Inc. | $52.00 to $50.00 | |
| 2015-12-17 | Reiterated Rating | Needham & Company LLC | Buy | $64.00 |
| 2015-12-10 | Reiterated Rating | Brean Capital | Buy | $70.00 |
| 2015-11-20 | Reiterated Rating | Brean Capital | Buy | $70.00 |
| 2015-11-20 | Reiterated Rating | Oppenheimer | Market Perform | |
| 2015-11-19 | Reiterated Rating | Needham & Company LLC | Buy | $64.00 |
| 2015-11-18 | Initiated Coverage | JMP Securities | Market Perform | $72.00 |
| 2015-11-17 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2015-11-17 | Reiterated Rating | Stephens | Buy | |
| 2015-11-13 | Lower Price Target | Mizuho | Buy | $70.00 to $65.00 |
| 2015-11-09 | Reiterated Rating | Pacific Crest | Equal Weight | |
| 2015-11-06 | Lower Price Target | BMO Capital Markets | Outperform | $80.00 to $68.00 |
| 2015-11-06 | Lower Price Target | Barclays | Equal Weight | $50.00 to $46.00 |
| 2015-11-06 | Lower Price Target | MKM Partners | Buy | $72.00 to $71.00 |
| 2015-11-06 | Lower Price Target | Needham & Company LLC | Buy | $68.00 to $64.00 |
| 2015-11-06 | Reiterated Rating | Brean Capital | Buy | $80.00 to $70.00 |
| 2015-10-20 | Initiated Coverage | Drexel Hamilton | Buy | $80.00 |
| 2015-10-16 | Lower Price Target | Mizuho | $80.00 to $70.00 | |
| 2015-10-13 | Reiterated Rating | Barclays | Equal Weight | $65.00 to $50.00 |
| 2015-10-01 | Initiated Coverage | Citigroup Inc. | Neutral | $49.00 |
| 2015-09-28 | Downgrade | Pacific Crest | Overweight to Sector Perform | |
| 2015-09-25 | Reiterated Rating | Barclays | Buy | |
| 2015-09-25 | Upgrade | Canaccord Genuity | Buy | $77.00 |
| 2015-09-24 | Lower Price Target | Needham & Company LLC | Buy | $82.00 to $68.00 |
| 2015-09-21 | Reiterated Rating | Brean Capital | Buy | |
| 2015-09-15 | Reiterated Rating | Brean Capital | Buy | $80.00 |
| 2015-09-08 | Lower Price Target | Pacific Crest | Overweight | $80.00 to $70.00 |
| 2015-09-01 | Initiated Coverage | Credit Agricole | Outperform | |
| 2015-08-31 | Initiated Coverage | CLSA | Outperform | $64.00 |
| 2015-08-31 | Initiated Coverage | Credit Agricole | Outperform | $64.00 |
| 2015-08-13 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2015-07-31 | Lower Price Target | KeyBanc | Overweight | $85.00 to $80.00 |
| 2015-07-31 | Lower Price Target | KeyCorp | Overweight | $85.00 to $80.00 |
| 2015-07-30 | Lower Price Target | Barclays | Equal Weight | $80.00 to $65.00 |
| 2015-07-30 | Lower Price Target | Northland Capital Partners | $88.50 to $75.00 | |
| 2015-07-30 | Lower Price Target | MKM Partners | Buy | $95.00 to $77.00 |
| 2015-07-30 | Lower Price Target | Canaccord Genuity | Buy | $89.00 to $77.00 |
| 2015-07-30 | Lower Price Target | Needham & Company LLC | Buy | $88.00 to $82.00 |
| 2015-07-30 | Lower Price Target | Ascendiant Capital Markets | Buy | $90.00 to $80.00 |
| 2015-07-30 | Lower Price Target | Brean Capital | Buy | $92.00 to $80.00 |
| 2015-07-30 | Lower Price Target | Northland Securities | Outperform | $88.50 to $75.00 |
| 2015-07-30 | Lower Price Target | Mizuho | Buy | $92.00 to $80.00 |
| 2015-07-22 | Reiterated Rating | Pacific Crest | Overweight | $85.00 |
| 2015-07-22 | Reiterated Rating | Brean Capital | Buy | $95.00 to $92.00 |
| 2015-07-14 | Initiated Coverage | Mizuho | Buy | $92.00 |
| 2015-06-22 | Reiterated Rating | Pacific Crest | Overweight | $80.00 |
| 2015-06-17 | Reiterated Rating | Brean Capital | Buy | $95.00 |
| 2015-05-22 | Initiated Coverage | Goldman Sachs | Buy | $98.00 |
| 2015-05-08 | Boost Price Target | Northland Securities | Outperform | $82.50 to $88.50 |
| 2015-05-07 | Boost Price Target | Canaccord Genuity | Buy | $85.00 to $89.00 |
| 2015-05-07 | Boost Price Target | Barclays | Equal Weight | $65.00 to $70.00 |
| 2015-05-07 | Boost Price Target | Ascendiant Capital Markets | Buy to Buy | $86.00 to $90.00 |
| 2015-05-07 | Boost Price Target | Craig Hallum | Buy | $84.00 to $90.00 |
| 2015-05-07 | Upgrade | Needham & Company LLC | Hold to Buy | $88.00 |
| 2015-05-05 | Reiterated Rating | Pacific Crest | Overweight | $80.00 |
| 2015-04-10 | Boost Price Target | Canaccord Genuity | Buy | $81.00 to $85.00 |
| 2015-04-02 | Boost Price Target | Brean Capital | Buy | $85.00 to $95.00 |
| 2015-03-16 | Upgrade | DA Davidson | Neutral to Buy | $70.00 to $100.00 |
| 2015-03-02 | Set Price Target | Canaccord Genuity | Buy | $81.00 |
| 2015-02-17 | Set Price Target | Brean Capital | Buy | $85.00 |
| 2015-02-08 | Reiterated Rating | Brean Capital | Buy | $85.00 |
| 2015-01-29 | Boost Price Target | MKM Partners | Buy | $73.00 to $87.00 |
| 2015-01-29 | Boost Price Target | DA Davidson | $68.00 to $70.00 | |
| 2015-01-29 | Initiated Coverage | Ascendiant Capital Markets | Buy | $86.00 |
| 2015-01-29 | Upgrade | Northland Securities | Market Perform to Outperform | $68.25 to $82.50 |
| 2015-01-16 | Initiated Coverage | Brean Capital | Buy | $80.00 |
| 2015-01-15 | Initiated Coverage | Charter Equity | Buy | |
| 2015-01-13 | Initiated Coverage | Oppenheimer | Market Perform | |
| 2015-01-13 | Upgrade | BMO Capital Markets | Market Perform to Outperform | $68.00 to $80.00 |
| 2015-01-13 | Initiated Coverage | Northland Securities | Market Perform | $68.25 |
| 2015-01-08 | Initiated Coverage | Craig Hallum | Buy | $76.00 |
| 2015-01-07 | Initiated Coverage | Raymond James | Strong-Buy | $77.00 |
| 2015-01-05 | Reiterated Rating | Canaccord Genuity | Buy | $79.00 |
| 2015-01-05 | Initiated Coverage | Pacific Crest | Outperform | $80.00 |
| 2015-01-05 | Initiated Coverage | BMO Capital Markets | Market Perform | $68.00 |
| 2015-01-05 | Initiated Coverage | Barclays | Equal Weight | $65.00 |
| 2015-01-02 | Initiated Coverage | Bank of America | Buy | |
| 2015-01-02 | Reiterated Rating | MKM Partners | Buy | $73.00 |
| 2016-07-06 | Reiterated Rating | Drexel Hamilton | Buy | |
| 2016-07-06 | Reiterated Rating | KeyCorp | Hold | |
| 2016-07-01 | Downgrade | Mizuho | Buy to Neutral | $55.00 |
| 2016-06-27 | Initiated Coverage | Morgan Stanley | Equal to Equal Weight | $56.00 |
| 2016-06-15 | Reiterated Rating | Brean Capital | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In QRVO 402 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 11.95M |
| BlackRock Inc. | 8.23M |
| BAUPOST GROUP LLC/MA | 6.78M |
| Capital Research Global Investors | 5.61M |
| Boston Partners | 4.87M |
| STATE STREET CORP | 4.67M |
| Vulcan Value Partners, LLC | 3.44M |
| BlackRock Institutional Trust Company, N.A. | 3.42M |
| BlackRock Fund Advisors | 2.67M |
| MANNING & NAPIER ADVISORS LLC | 2.44M |
| AMERIPRISE FINANCIAL INC | 2.18M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.16M |
| LSV ASSET MANAGEMENT | 1.74M |
| Invesco Ltd. | 1.67M |
| DIMENSIONAL FUND ADVISORS LP | 1.58M |
UM